71% OffDecapeptyl 0.1mg Injection
Injection
- Composition
- —
- Manufacturer
- Ferring Pharma
- Order within -- and we dispatch today
About Decapeptyl 0.1mg Injection
Decapeptyl 0.1mg Injection: Advanced Pituitary Down-Regulation for IVF Cycles
Decapeptyl 0.1mg Injection is an ultra-pure, short-acting injectable solution formulated with triptorelin acetate, a synthetic analogue of natural luteinizing hormone-releasing hormone (LHRH). By delivering a precise daily dose, Decapeptyl provides reproductive endocrinologists with complete control over a patient's hormonal cycle, making it a foundational treatment for controlled ovarian hyperstimulation (COH) programs.
Clinical Mechanism of Action: How Decapeptyl Works
Initial Flare Effect: Upon administration, triptorelin initially stimulates the pituitary gland, causing a temporary surge in the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).
Pituitary Desensitization (Down-Regulation): With continuous daily dosing, Decapeptyl down-regulates and desensitizes pituitary GnRH receptors. This halts native LH and FSH production, putting the ovaries into a temporary, reversible quiescent state. This blockade prevents spontaneous ovulation, allowing administered gonadotropins to uniformly mature multiple eggs for extraction.
Therapeutic Indications: What Conditions Does Decapeptyl Treat?
| Clinical Indication | Therapy Framework | Therapeutic Benefit & Mechanism |
| In Vitro Fertilization (IVF) | Pituitary Down-Regulation | Suppresses endogenous LH surges to prevent premature egg release before retrieval. |
| ICSI Protocols | Advanced Fertility Cycles | Synchronizes follicular growth to maximize the retrieval yield of viable oocytes. |
| Endometriosis Management | Off-Label Hormone Suppression | Lowers systemic estrogen levels to suppress and alleviate painful endometrial lesions. |
COMPARATIVE ANALYSIS: IVF DOWN-REGULATION OPTIONS
| Product Name | Active Compound | Mechanism Class | Primary Clinical Distinction |
| Decapeptyl 0.1mg | Triptorelin Acetate | GnRH Agonist (Short-Acting) | Reversible down-regulation via initial receptor saturation; highly flexible daily dosing. |
| Cetrorelix 0.25mg | Cetrorelix Acetate | GnRH Antagonist | Immediate hormone suppression without an initial flare; requires fewer total injection days. |
| Lupron 1mg | Leuprolide Acetate | GnRH Agonist (Short-Acting) | Alternative daily agonist; clinical preference varies by clinic and individual protocol layout. |
Uses
Precise Cycle Control: Eliminates the risk of canceled IVF cycles due to unexpected, premature ovulation.
Short-Acting Flexbility: The daily 0.1mg formulation clears from the system rapidly, allowing fertility teams to make agile, real-time adjustments to stimulation protocols.
Dual IVF Utility: Can be used early in long protocols for down-regulation, or late in antagonist protocols as an alternative "trigger shot" to significantly reduce the risk of Ovarian Hyperstimulation Syndrome (OHSS).
High-Precision Injection: Supplied in convenient single-dose vials or pre-filled syringes optimized for comfortable, fine-needle subcutaneous delivery.
Dosage and how to take it
Strict Protocol Adherence: Must be administered exactly on the specific cycle days designated by your reproductive endocrinologist. It is typically given once daily at the exact same time each day.
Administration Site: Delivered via subcutaneous (SC) injection into the lower abdominal wall or thigh. Clean the area thoroughly and rotate the precise puncture spot daily to prevent localized skin sensitivity.
Cold-Chain Maintenance: Unused boxes must be stored in a refrigerator between 2°C and 8°C. Protect the vials from freezing and direct exposure to light.
Possible side effects
Injection Site Reactions: Temporary, mild redness, swelling, bruising, or localized itching at the injection site may occur.
Hypoestrogenic Symptoms: Due to temporary estrogen suppression, patients may experience transient hot flashes, night sweats, vaginal dryness, mood shifts, or headaches.
Contraindications: Do not use if you have an unconfirmed pregnancy, are breastfeeding, or have a known hypersensitivity to triptorelin acetate or other GnRH analogues.
